Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct;41(10):3954-3963.
doi: 10.1016/j.arthro.2025.03.034. Epub 2025 Mar 25.

Increased Use of Hip Arthroscopy in the United States from 2015 to 2023 and Projected Growth Through 2030

Jeremy M Adelstein  1 , Parshva A Sanghvi  2 , Kira Smith  3 , Robert J Burkhart  3 , Andrew J Moyal  3 , Luc M Fortier  3 , Bhargavi Maheshwer  3 , Jacob G Calcei  3 , James E Voos  3 , Michael J Salata  3
Affiliations

Increased Use of Hip Arthroscopy in the United States from 2015 to 2023 and Projected Growth Through 2030

Jeremy M Adelstein et al. Arthroscopy. 2025 Oct.

Abstract

Purpose: To assess hip arthroscopy epidemiology in the United States from 2015 to 2023 and provide projections through 2030, as well as analyze rates of postoperative complications.

Methods: The TriNetX/U.S. Collaborative Networks database was used to identify patients aged 10 to 89 years who underwent hip arthroscopy in the United States from 2015 to 2023. Demographic information, such as age, sex, and body mass index, was analyzed. Prevalence (P), incidence proportion (IP), and incidence rate (IR) were measured. Regression modeling was used to project through 2030. Complications such as femoral neck fracture, hemarthrosis, septic arthritis, hip dislocation/instability, avascular necrosis, osteoarthritis (OA), and conversion to total hip arthroplasty (THA) were also analyzed.

Results: In TriNetX, 25,903 patients underwent hip arthroscopy in the United States from 2015 to 2023. In 2023, 2,427 hip arthroscopies occurred, a 97% increase compared with 1,236 in 2015. Annual database incidence is projected to increase to more than 4,800 cases by 2030. In 2023, prevalence was greatest in female patients aged 20 to 24 years, whereas incidence was greatest in female patients aged 15 to 19 years. Femoral neck fracture, hip dislocation, septic arthritis, and avascular necrosis occurred in <1% of patients within 2 and 5 years postoperatively. Male patients had greater risk for all complications aside from hemarthrosis and trochanteric bursitis, which were greater in female patients at 5 years. In total, 17% of patients developed OA, with 9.8% requiring conversion to THA within 5 years. Most (>80%) who converted to THA were older than 30 years of age at time of hip arthroscopy. There were no sex-based differences in conversion to THA.

Conclusions: Our analysis reveals a substantial increase in hip arthroscopy, with projections indicating a continued surge. Despite low complication rates, male patients were found to be at greater risk of most complications aside from hemarthrosis and trochanteric bursitis, which were higher in female patients. The incidence of developing OA and conversion to THA remains significant.

Level of evidence: Level IV, retrospective case series.

PubMed Disclaimer

Conflict of interest statement

Disclosures The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: J.G.C. reports consulting or advisory for Smith & Nephew. J.E.V. reports consulting or advisory for Johnson & Johnson AG Switzerland and Arthrex. M.J.S. reports consulting or advisory for Stryker. All other authors (J.M.A., P.A.S., K.S., R.J.B., A.J.M., L.M.F., B.M.) declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.